The African Centre for Disease Control and World Health Organization have raised the alarm following a drastic uptick in mpox cases. This surge is being driven by a new strain of the virus. Elri Voigt reports about what we know so far and potential implications for South Africa.
A Competition Commission probe recently resulted in a patent on an important tuberculosis medicine being dropped in South Africa. Twenty years ago, a similar Competition Commission case resulted in a settlement that helped drive down the prices of several antiretrovirals, thereby helping to set the stage for the country’s HIV treatment programme. Fatima Hassan and Leena Menghaney connect the dots between the two landmark cases and map out what has and has not changed over the last two decades.
In recent years, shortages of snake antivenom have plagued South Africa and much of the globe. Even when antivenom is available, potentially serious side effects often limit its use. Jesse Copelyn unpacks the fascinating details behind the antivenom products that might save your life and takes a look at a promising experimental treatment.
Burn injury has been described as the forgotten global public health crisis. Dr Nikki Allorto says that while it may be a neglected issue in South Africa, she is making sure her patients feel seen, heard and cared for. Sue Segar spent time with her on ward and clinic rounds at Greys Hospital in KwaZulu-Natal.
The South African government has adopted a national target to bring the blood sugar levels of people with diabetes under control. But beyond the target, the country’s response to diabetes is falling far short. In this Spotlight special briefing, Catherine Tomlinson looks at what the country needs to do to better manage this often fatal disease and how we can draw lessons from the response to HIV.
Mireille Wenger was recently appointed to the Western Cape’s top health job. Biénne Huisman chatted to Wenger about health policy, child health, and the challenge of providing quality public health services at a time of shrinking budgets.
In South Africa, taking HIV treatment means taking one or more antiretroviral tablets a day. People in some other countries have the additional option of treatment in the form of two injections administered every two months. Elri Voigt unpacks why long-acting HIV treatment is not available in South Africa and asks why the push for HIV prevention jabs has been so much stronger than that for HIV treatment jabs.
Working with women in Giyani in Limpopo sparked the flame for Professor Kathy Kahn to dedicate her research career to the rural community she says she is “bonded to”. She tells Spotlight’s Ufrieda Ho why it’s been this way since she was a student in medical school.
Last year a South African woman took a multibillion-dollar United States pharmaceutical company to court with the aim of securing access to life-changing cystic fibrosis medicines. That case has now been dropped following a reduction in the price charged for the medicines in South Africa. Catherine Tomlinson reports.
While we focus here on the nine deaths that Judge Mmonoa Teffo found to be unnatural, there were 144 deaths associated with the Life Esidimeni tragedy. Ultimately, these were human beings and for the world to know what happened to them is better than the world not knowing.
Former ANC member, now with ActionSA, Kgosi Letlape was recently elected to parliament’s health committee. Biénne Huisman spoke to the past president of the Health Professions Council of SA about leaving the ANC, healthcare in the country, gender-based violence, and the murder of his daughter.
Taking antiretrovirals to prevent HIV infection mostly still involves swallowing one or more pills a day. Some long-acting products that work for a month or two at a time have been approved but are not yet in wide use in South Africa. As delegates gathered for the 25th International AIDS Conference (AIDS 2024) last week, Elri Voigt takes stock of the latest developments in this fast-moving field.